Structural Alterations in the Translational Attenuator of Constitutively Expressed ErmC Genes

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 1999 Jul 2

PMID 10390222

Citations 20

Authors

C Werckenthin

S Schwarz

H Westh

Affiliations

Soon will be listed here.

Abstract

Sequence deletions of 16, 59, and 111 bp as well as a tandem duplication of 272 bp with respect to the corresponding sequence of pT48 were identified in the regulatory regions of constitutively expressed ermC genes. Constitutive ermC gene expression as a consequence of these structural alterations is based on either the prevention of the formation of mRNA secondary structures in the translational attenuator or the preferential formation of those mRNA secondary structures which do not interfere with the translation of the ermC transcripts. A model for the development of sequence deletions in the ermC translational attenuator by homologous recombination is presented and experimentally tested by in vitro selection of constitutively expressed mutants in staphylococcal strains deficient and proficient in homologous recombination.

Citing Articles

Regulation of erm(T) MLS phenotype expression in the emergent emm92 type group A Streptococcus.

Powell L, Choi S, Grund M, Demkowicz R, Berisio R, LaSala P NPJ Antimicrob Resist. 2025; 2(1):44.

PMID: 39843607 PMC: 11721399. DOI: 10.1038/s44259-024-00062-3.

Molecular basis and evolutionary cost of a novel macrolides/lincosamides resistance phenotype in .

Xu R, Wang Q, Wu S, Wang H, Song T, Zhao C Microbiol Spectr. 2023; :e0044123.

PMID: 37724875 PMC: 10655708. DOI: 10.1128/spectrum.00441-23.

Mechanisms of Bacterial Resistance to Antimicrobial Agents.

van Duijkeren E, Schink A, Roberts M, Wang Y, Schwarz S Microbiol Spectr. 2018; 6(1).

PMID: 29327680 PMC: 11633570. DOI: 10.1128/microbiolspec.ARBA-0019-2017.

A shared population of epidemic methicillin-resistant Staphylococcus aureus 15 circulates in humans and companion animals.

Harrison E, Weinert L, Holden M, Welch J, Wilson K, Morgan F mBio. 2014; 5(3):e00985-13.

PMID: 24825010 PMC: 4030480. DOI: 10.1128/mBio.00985-13.

Multiple mutations lead to MexXY-OprM-dependent aminoglycoside resistance in clinical strains of Pseudomonas aeruginosa.

Guenard S, Muller C, Monlezun L, Benas P, Broutin I, Jeannot K Antimicrob Agents Chemother. 2013; 58(1):221-8.

PMID: 24145539 PMC: 3910787. DOI: 10.1128/AAC.01252-13.

References

Monod M, Denoya C, Dubnau D . Sequence and properties of pIM13, a macrolide-lincosamide-streptogramin B resistance plasmid from Bacillus subtilis. J Bacteriol. 1986; 167(1):138-47. PMC: 212852. DOI: 10.1128/jb.167.1.138-147.1986. View

Weisblum B . Inducible resistance to macrolides, lincosamides and streptogramin type B antibiotics: the resistance phenotype, its biological diversity, and structural elements that regulate expression--a review. J Antimicrob Chemother. 1985; 16 Suppl A:63-90. DOI: 10.1093/jac/16.suppl_a.63. View

Allen N . Macrolide resistance in Staphylococcus aureus: inducers of macrolide resistance. Antimicrob Agents Chemother. 1977; 11(4):669-74. PMC: 352047. DOI: 10.1128/AAC.11.4.669. View

Weisblum B . Insights into erythromycin action from studies of its activity as inducer of resistance. Antimicrob Agents Chemother. 1995; 39(4):797-805. PMC: 162632. DOI: 10.1128/AAC.39.4.797. View

Lodder G, Werckenthin C, Schwarz S, Dyke K . Molecular analysis of naturally occuring ermC-encoding plasmids in staphylococci isolated from animals with and without previous contact with macrolide/lincosamide antibiotics. FEMS Immunol Med Microbiol. 1997; 18(1):7-15. DOI: 10.1111/j.1574-695X.1997.tb01022.x. View

Lampson B, Parisi J . Nucleotide sequence of the constitutive macrolide-lincosamide-streptogramin B resistance plasmid pNE131 from Staphylococcus epidermidis and homologies with Staphylococcus aureus plasmids pE194 and pSN2. J Bacteriol. 1986; 167(3):888-92. PMC: 215956. DOI: 10.1128/jb.167.3.888-892.1986. View

Catchpole I, Thomas C, Davies A, DYKE K . The nucleotide sequence of Staphylococcus aureus plasmid pT48 conferring inducible macrolide-lincosamide-streptogramin B resistance and comparison with similar plasmids expressing constitutive resistance. J Gen Microbiol. 1988; 134(3):697-709. DOI: 10.1099/00221287-134-3-697. View

Tinoco Jr I, Borer P, Dengler B, Levin M, Uhlenbeck O, Crothers D . Improved estimation of secondary structure in ribonucleic acids. Nat New Biol. 1973; 246(150):40-1. DOI: 10.1038/newbio246040a0. View

Somkuti G, Solaiman D, Steinberg D . Molecular characterization of the erythromycin resistance plasmid pPV142 from Staphylococcus simulans. FEMS Microbiol Lett. 1998; 165(2):281-8. DOI: 10.1111/j.1574-6968.1998.tb13158.x. View

10.

Horinouchi S, Weisblum B . Nucleotide sequence and functional map of pE194, a plasmid that specifies inducible resistance to macrolide, lincosamide, and streptogramin type B antibodies. J Bacteriol. 1982; 150(2):804-14. PMC: 216433. DOI: 10.1128/jb.150.2.804-814.1982. View

11.

Schwarz S, Lange C, Werckenthin C . Molecular analysis of the macrolide-lincosamide resistance gene region of a novel plasmid from Staphylococcus hyicus. J Med Microbiol. 1998; 47(1):63-70. DOI: 10.1099/00222615-47-1-63. View

12.

Lyon B, Skurray R . Antimicrobial resistance of Staphylococcus aureus: genetic basis. Microbiol Rev. 1987; 51(1):88-134. PMC: 373094. DOI: 10.1128/mr.51.1.88-134.1987. View

13.

Werckenthin C, Schwarz S, Roberts M . Integration of pT181-like tetracycline resistance plasmids into large staphylococcal plasmids involves IS257. Antimicrob Agents Chemother. 1996; 40(11):2542-4. PMC: 163571. DOI: 10.1128/AAC.40.11.2542. View

14.

Chung W, Werckenthin C, Schwarz S, Roberts M . Host range of the ermF rRNA methylase gene in bacteria of human and animal origin. J Antimicrob Chemother. 1999; 43(1):5-14. DOI: 10.1093/jac/43.1.5. View

15.

S Oliveira S, Murphy E, Gamon M, Bastos M . pRJ5: a naturally occurring Staphylococcus aureus plasmid expressing constitutive macrolide-lincosamide-streptogramin B resistance contains a tandem duplication in the leader region of the ermC gene. J Gen Microbiol. 1993; 139(7):1461-7. DOI: 10.1099/00221287-139-7-1461. View

16.

Lodder G, Schwarz S, Gregory P, Dyke K . Tandem duplication in ermC translational attenuator of the macrolide-lincosamide-streptogramin B resistance plasmid pSES6 from Staphylococcus equorum. Antimicrob Agents Chemother. 1996; 40(1):215-7. PMC: 163085. DOI: 10.1128/AAC.40.1.215. View

17.

Catchpole I, DYKE K . A Staphylococcus aureus plasmid that specifies constitutive macrolide-lincosamide-streptogramin B resistance contains a novel deletion in the ermC attenuator. FEMS Microbiol Lett. 1990; 57(1-2):43-7. DOI: 10.1016/0378-1097(90)90410-r. View

18.

Somkuti G, Solaiman D, Steinberg D . Molecular properties of the erythromycin resistance plasmid pPV141 from Staphylococcus chromogenes. Plasmid. 1997; 37(2):119-27. DOI: 10.1006/plas.1997.1278. View

19.

Bayles K, Brunskill E, Iandolo J, Hruska L, Huang S, Pattee P . A genetic and molecular characterization of the recA gene from Staphylococcus aureus. Gene. 1994; 147(1):13-20. DOI: 10.1016/0378-1119(94)90033-7. View

20.

Weisblum B . Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother. 1995; 39(3):577-85. PMC: 162587. DOI: 10.1128/AAC.39.3.577. View